TrialClinical rheumatology2023

Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program.

Adriana Maria Kakehasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.